On the origin and growth of gliomas

Anticancer Research

Volumn 30, Issue 6, 2010, Pages 1977-1998

  Schiffer, Davide ^a   Annovazzi, Laura ^a   Caldera, Valentina ^a   Mellai, Marta ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Brain adjecent tissue; CD133; Gliomas; Markers; Nestin; Origin; Review; Stem cells; Subventricular zone

Indexed keywords

CHEMOKINE; CYTOKINE; EXCITATORY AMINO ACID TRANSPORTER; FIBROBLAST GROWTH FACTOR 1; GLUTAMATE TRANSPORTER; INTERLEUKIN 8; METHYLNITROSOUREA; NESTIN; NEUROTROPHIN; PLATELET DERIVED GROWTH FACTOR; TRANSFORMING GROWTH FACTOR ALPHA; VASCULOTROPIN; VIMENTIN;

ANGIOGENESIS; ANTIGEN EXPRESSION; CANCER STEM CELL; CARCINOGENESIS; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; GENETIC ENGINEERING; GLIA; GLIOBLASTOMA; GLIOMA; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HYPOXIA; NERVOUS SYSTEM DEVELOPMENT; NEURAL STEM CELL; NEUROTROPISM; NONHUMAN; PRIORITY JOURNAL; REVIEW; STEM CELL NICHE; TUMOR GROWTH;

ANIMALS; ANTIGENS, CD; BRAIN NEOPLASMS; GLIOMA; GLYCOPROTEINS; HUMANS; INTERMEDIATE FILAMENT PROTEINS; NEOPLASTIC STEM CELLS; NEOVASCULARIZATION, PATHOLOGIC; NERVE TISSUE PROTEINS; NEUROGLIA; NEURONS; PEPTIDES; STEM CELLS;

EID: 77955081020     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (202)

1. Bailey P and Cushing H: A Classification of the Tumors of the Glioma Group on a Histogenetic Basis with a Correlation Study of Prognosis. Lippincott, Philadelphia, 1926.
2. Boveri T: Zur Frage der Entstehung maligner Tumoren. Gustav Fisher, Jena. 1914.
3. Van der Horst L: Application of the field theory to gliomata. J Neuropathol Exp Neurol 14: 369-375, 1955.
4. Holland EC: Gliomagenesis: genetic alterations and mouse models. Nature Rev Genet 2: 120-129, 2001.
5. Kobayashi D, Kobayashi M, Matsumoto K, Ogura T, Nakafuku M and Shimamura K: Early subdivisions in the neural plate define distinct competence for inductive signals. Development 129: 83-93, 2001.
6. Noble M: The O-2A lineage: from rats to humans. Rec Res Cancer Res 135: 67-75, 1994.
7. Uchida N, Buck DV, He D, Reitsma RJ, Masek M, Phan TV, Tsukamoto AS, Gage FH and Weissman IL: Direct isolation of human central nervous system stem cells. PNAS USA 97: 14720-14725, 2000.
8. Sakakibara S, Nakamura Y, Yoshida T, Shibata S, Koike M, Takano H, Ueda S, Uchiyama Y, Noda T and Okano H: RNA-binding protein Musashi family: roles for CNS stem cells and a subpopulation of ependymal cells revealed by targeted disruption and antisense ablation. PNAS USA 99: 15194-15199, 2002.
9. D'Amour KA and Cage FH: Genetic and functional differences between multipotent neural and pluripotent embryonic stem cells. PNAS USA 100: 11866-11872, 2003.
10. Goldman JE: Glial differentiation and lineages. J Neurosci Res 59: 410-412, 2000.
11. Reynolds BA and Weiss S: Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science 255: 1707-1710, 1992.
12. Reynolds BA and Rietze RL: Neural stem cells and neurospheres-re- evaluating the relationship. Nat Methods 2: 333-336, 2005.
13. Garcia AD, Doan NB, Imura T, Bush TG and Sofroniev MV: GFAP-expressing progenitors are the principal source of constitutive neurogenesis in adult mouse forebrain. Nat Neurosci 7: 1233-1241, 2004.
14. Doetsch F, García-Verdugo JM and Alvarez-Buylla A: Cellular composition and three-dimensional organization of the subventricular germinal zone in the adult mammalian brain. J Neurosci 17: 5046-5061, 1997.
15. Alvarez-Buylla A, García-Verdugo JM and Tramontin AD: A unified hypothesis on the lineage of neural stem cells. Nat Rev Neurosci 2: 287-293, 2001.
16. Veeravagu A, Bababeygy SR, Kalani MY, Hou LC and Tse V: The cancer stem cell-vascular niche complex in brain tumor formation. Stem cells and Dev 17: 859-867, 2008.
17. Palmer TD, Willhoite AR and Gage FH: Vascular niche for adult hippocampal neurogenesis. J Comp Neurol 425: 479-494, 2000.
18. Doetsch F: The glia identity of neural stem cells. Nature Neurosci 6: 1127-1134, 2003.
19. Alvarez-Buylla A, Kohwi M, Nguyen TM and Merkle FT: The heterogeneity of adult neural stem cells and the emerging complexity of their niche. Cold Spring Harb Symp Quant Biol 73: 357-365, 2008.
20. Doetsch F: A niche for adult neural stem cells. Curr Opin Gen Dev 13: 543-550, 2003.
21. Jackson EL and Alvarez-Buylla A: Characterization of adult neural stem cells and their relation to brain tumors. Cells Tissues Organs 188: 212-224, 2008.
22. Gage FH: Mammalian neural stem cells. Science 287: 1433-1438, 2000.
23. Gage FH: Neurogenesis in the adult brain. J Neurosci 22: 612-613, 2002.
24. Marshall CAG, Novitch BG and Goldman JE: Olig2 directs astrocyte and oligodendrocyte formation in postnatal subventricular zone cells. J Neurosci 23: 7289-7298, 2005.
25. Zhou Q, Wang S and Anderson DJ: Identification of a novel family of oligodendrocyte lineage-specific basic helix-loop-helix transcription factors. Neuron 25: 331-343, 2000.
26. Lu QR, Sun T, Zhu Z, Ma N, Garcia M, Stiles CD and Rowitch DH: Common developmental requirement for Oligo function indicates a motor neuron/oligodendrocyte connection. Cell 109: 75-86, 2002.
27. Tamura Y, Kataoka Y, Cui Y, Takamori Y, Watanabe Y and Yamada H: Multi-directional differentiation of doublecortin- and NG2-immunopositive progenitor cells in the adult rat neocortex in vivo. Eur J Neurosci 25: 3489-3496, 2007.
28. Stiles CD and Rowitch DF: Glioma stem cells: a midterm exam. Neuron 58: 832-845, 2008.
29. Ever L and Gaiano N: Radial 'glial' progenitors: neurogenesis and signaling. Curr Opin Neurobiol 15: 29-33, 2005.
30. Purow BW, Haque RM, Noel MW, Su Q, Burdick MJ, Lee J, Sundaresan T, Pastorino S, Park JK, Mikolaenko I, Maric D, Eberhart CG and Fine HA: Expression of Notch-1 and its ligands, Delta-like-1 and Jagged-1, is critical for glioma cells survival and proliferation. Cancer Res 65: 2353-2363, 2005.
31. Hartfuss E, Förster E, Bock HH, Hack MA, Leprince P, Luque JM, Herz J, Frotscher M and Götz M: Reelin signaling directly affects radial glia morphology and biochemical maturation. Development 130: 4597-4609, 2003.
32. Schmeche DE and Rakic P: A Golgi study of radial glia cells in developing monkey telencephalon: Morphogenesis and transformation into astrocytes. Anat Embryol 156: 115-152, 1979.
33. Laywell ED, Rakic P, Kukekov VG, Holland EC and Steindler DA: Identification of a multipotent astrocytic stem cell in the immature and adult mouse brain. PNAS USA 97: 13883-13888, 2000.
34. Laywell ED, Steindler DA and Silver DJ: Astrocytic stem cells in the adult brain. Neurosurg Clin N Am 18: 21-30, 2007.
35. Grossi-Paoletti E, Paoletti P, Pezzotta S, Schiffer D and Fabiani A: Tumors of the nervous system induced by ethylnitrosourea administered either intracerebrally of subcutaneously to newborn rats. Morphological and biochemical characteristics. J Neurosurg 37: 580-590, 1972.
36. Schiffer D, Fabiani A, Grossi-Paoletti E and Paoletti P: Experimental brain tumors induced in rats by nitrosourea derivatives. Part I. Morphological aspects of methylnitrosourea tumours. J Neurol Sci 11: 559-572, 1970.
37. Schiffer D, Giordana MT, Pezzotta S, Lechner C and Paoletti P: Cerebral tumors induced by transplacental ENU: study of the different tumoral stages, particularly of early proliferations. Acta Neuropathol 41: 27-31, 1978.
38. Schiffer D, Giordana MT, Mauro A, Racagni G, Bruno F, Pezzotta S and Paoletti P: Experimental brain tumors by transplacental ENU. Multifactorial study of the latency period. Acta Neuropathol 49: 117-122, 1980.
39. Pilkington GJ and Lantos PL: The development of experimental brain tumors. A sequential light and electron microscope study of subependymal plate. II. Microtumors. Acta Neuropathol 45: 177-185, 1979.
40. Kleihues P and Rajewsky MF: Clinical neuro-oncogenesis: role of structural DNA modifications, DNA repair and neural target cell population. Progr Exp Tum Res 27: 1-16, 1984.
41. 6-ethylguanine in rat brain DNA. Correlation with nervous system specific carcinogenesis by ethylnitrosourea. PNAS USA 71: 639-653, 1974.
42. Bosch DA: Short- and long-term effects of methyl- and ethyl-nitrosourea (MNU & ENU) on the developing nervous system of the rat. II Short term: concluding remarks on chemical neuro-oncogenesis. Acta Neurol Scand 55: 106-122, 1977.
43. Leonard JR, D'Sa C, Klocke BJ and Roth KA: Neural precursor cell apoptosis and glial tumorigenesis following transplacental ethyl-nitrosourea exposure. Oncogene 20: 8281-8286, 2001.
44. Schiffer D: Brain Tumors. Biology, Pathology and Clinical Correlates. Springer, Heidelberg, 1997.
45. Rubinstein LJ: Embryonal central neuroepithelial tumors and their differentiating potential: a cytogenetic view of a complex neuro-oncological problem. J Neurosurg 62: 795-805, 1985.
46. Rubinstein LJ: The correlation of neoplastic vulnerability with central neuroepithelial cytogeny and glioma differentiation. J Neuro-Oncol 5: 11-27, 1987.
47. Shih AH and Holland EC: Developmental neurobiology and the origin of brain tumors. J Neuro-Oncol 70: 125-136, 2004.
48. Recht L, Jang T and Litofsky NS: Neural stem cells and neurooncology: Quo vadis? J Cell Biochem 88: 11-19, 2003.
49. Dai C and Holland EC: Astrocyte differentiation states and glioma formation. Cancer J 9: 72-81, 2003.
50. Bergmann A, Tugentman M, Shilo BZ and Steiler H: Regulation of cell number by MAPK-dependent control of apoptosis: a mechanism for trophic survival signaling. Dev Cell 2: 159-170, 2002.
51. Bonni A, Sun Y, Nadal-Vicens M, Bhatt A, Frank DA, Rozovsky I, Stahl N, Yancopoulos GD and Greenberg ME: Regulation of gliogenesis in the central nervous system by the Jak-Stat signaling pathway. Science 278: 477-483, 1997.
52. Takizawa T, Nakashima K, Namihira M, Ochiai W, Uemura A, Yanagisawa M, Fujita N, Nakao M and Taga T: DNA methylation is a critical cell-intrinsic determinant of astrocytic differentiation in the foetal brain. Dev Cell 1: 749-758, 2001.
53. Jackson EL, Garcia-Verduno JM, Gil-Perotin S, Roy M, Quinones-Hinojosa A, VandenBerg S and Alvarez-Buylla A: PDGFR alpha-positive B cells are neural stem cells in the adult SVZ that form glioma-like growths in response to increased PDGF signaling. Neuron 511: 187-199, 2006.
54. Assanah M, Lochhead R, Ogden A, Bruce J and Canoll P: Glia progenitors in adult white matter are driven to form malignant gliomas by platelet-derived growth factor-expressing retroviruses. J Neurosurg 26: 6781-6790, 2006.
55. Emmenegger BA and Wechsler-Reya RJ: Stem cells and the origin and propagation of brain tumors. J Child Neurol 23: 172-174, 2009.
56. Feinberg AP, Ohlsson R and Henikoff S: The epigenetic progenitor origin of human cancer. Nat Rev Genet 7: 21-33, 2006.
57. Uhrbom L, Dai C, Celestino J, Rosenblum M K, Fuller GN and Holland EC: Ink4a-Arf loss cooperates with Kras activation in astrocytes and neural progenitors to generate glioblastomas of various morphologies depending on activated Akt. Cancer Res 62: 5551-5558, 2002.
58. Sultana S, Zhou R, Sadagopan MS and Skalii O: Effects of growth factors and basement membrane proteins on the U-373 MG glioblastoma cells as determined by the expression of intermediate filament proteins. Am J Pathol 153: 1157-1168, 1998.
59. Zhou R and Skalli O: TGF-α differentially regulates GFAP, vimentin, and nestin gene expression in U-373 MG glioblastoma cells: correlation with cell shape and motility. Exp Cell Res 254: 269-278, 2000.
60. Pereira DS, Dorrell C, Ito CY, Gan OI, Murdoch B, Rao VN, Zou JP, Reddy ES and Dick JE: Retroviral transduction of TLS-ERG initiates a leukemogenic program in normal human hematopoietic cells. PNAS USA 95: 8239-8244, 1998.
61. Cairncross JG: The biology of astrocytomas: a lesson learned from chronic myelogenous leukemia hypothesis. J Neurooncol 5: 99-104, 1987.
62. Holland EC, Celestino C, Dai C, Schaefer L, Sawaya RE and Fuller GN: Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice. Nat Genet 25: 55-57, 2000.
63. Dai C, Celestino JC, Okada Y, Louis DN, Fuller GN and Holland EC: PGDF autocrine stimulation dedifferentiates and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vitro. Genes Dev 15: 1913-1925, 2001.
64. Lassman AB, Dai C, Fuller GN, Vickers AJ and Holland E: Overexpression of c-MYC promotes an undifferentiated phenotype in cultured astrocytes and allows elevated Ras and Akt signaling to induce gliomas from GFAP-expressing cells in mice. Neuron Glia Biol 1: 157-163, 2004.
65. Kraus JA, Koopmann J, Kaskel P, Maintz D, Brandner S, Schramm J, Louis DN, Wiestler OD and von Deimling A: Shared allelic losses on chromosome 1p and 19q suggest a common origin of oligodendroglioma and oligoastrocytoma. J Neuropathol Exp Neurol 54: 91-95, 1995.
66. Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J and Dirks PB: Identification of a cancer stem cell in human brain tumors. Cancer Res 63: 5821-5828, 2003.
67. Oliver TG and Wechsler-Reya RJ: Getting at the root and the stem of brain tumors. Neuron 42: 885-888, 2004.
68. Yuan X, Curtin J, Xiong Y, Liu G, Waschsmann-Hogiu S, Farkas DL, Black KL and Yu JS: Isolation of cancer stem cells from adult glioblastoma multiforme. Oncogene 23: 9392-9400, 2004.
69. Galli R, Binda E, Orfanelli U, Cipelletti B, Gritti A, De Vitis S, Fiocco R, Foroni C, Dimeco F and Vescovi A: Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res 64: 7011-7021, 2004.
70. Reya T, Morrison SJ, Clarke MF and Weissman IL: Stem cells, cancer, and cancer stem cells. Nature 414: 105-111, 2001.
71. Hill RP: Identifying cancer stem cells in solid tumors: case not proven. Cancer Res 66: 1891-1896, 2005.
72. Ignatova TN, Kukekov VG, Laywell BD, Suslov ON, Vrionis FD and Steindler DD: Human cortical glial tumors contain neural stem-like cells expressing astroglial neuronal markers in vitro. Glia 39: 193-206, 2002.
73. Varghese M, Olstorn H, Sandberg C, Vik-Mo E, Noordhuis P, Nistér M, Berg-Johnsen J, Moe MC and Langmoen IA: A comparison between stem cells from the adult human brain and from brain tumors. Neurosurgery 63: 1022-1034, 2008.
74. Singh SK, Clarke ID, Hide T and Dirks PB: Cancer stem cells in nervous system tumors. Oncogene 23: 7267-7273, 2004.
75. Beier D, Hau P, Proescholdt M, Lohmeier A, Wischhusen J, Oefner PJ, Aigner L, Brawanski A, Bogdahn U and Beier CP: CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles. Cancer Res 67: 4010-4015, 2007.
76. - tumor-initiating cells in adult human gliomas. Neurosurgery 62: 505-514, 2008.
77. Wang JC and Dick JR: Cancer stem cells: lessons from leukaemia. Trends Cell Biol 15: 494-501, 2008.
78. Joo KM, Kim SY, Jin X, Song SY, Kong DS, Lee JI, Jeon JW, Kim MH, Kang BG, Jung Y, Jin J, Hong SC, Park WY, Lee DS, Kim H and Nam DH: Clinical and biological implications of CD133-positive and CD133-negative cells in glioblastomas. Lab Invest 88: 808-815, 2008.
79. Yi JM, Tsai HC, Glöckner SC, Lin S, Ohm JE, Easwaran H, James CD, Costello JF, Riggins G, Eberhart CG, Laterra J, Vescovi AL, Ahuja N, Herman JG, Schuebel KE and Baylin SB: Abnormal DNA methylation of CD133 in colorectal and glioblastoma tumors. Cancer Res 68: 8094-8103, 2008.
80. Bao S, Wu O, McLendon RE, Hao Y, Shi Q, Hjelmeland AB, Dewhirst MW, Bigner DD and Rich JN: Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444: 756-7602, 2006.
81. Bao S, Wu Q, Sathornsumetee S, Hao Y, Li Z, Hjelmeland AB, Shi Q, McLendon RE, Bigner DD and Rich JN: Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor. Cancer Res 66: 843-748, 2006.
82. Christensen K, Schroder HD and Kristensen BW: CD133 identifies perivascular niches in grade II-IV astrocytomas. J Neurooncol 90: 157-170, 2008.
83. Zeppernick F, Ahmadi R, Campos B, Dictus C, Helmke BM, Becker N, Lichter P, Unterberg A, Radlwimmer B and Herold-Mende CC: Stem cell marker CD133 affects clinical outcome in glioma patients. Clin Cancer Res 14: 123-129, 2008.
84. Rebetz J, Tian D, Persson A, Widegren B, Salford LG, Englund E, Gisselsson D and Fan X: Glial progenitor-like phenotype in low-grade glioma and enhanced CD133-expression and neuronal lineage differentiation potential in high-grade glioma. PLoS One 3: e1936, 2008.
85. Beier D, Wischhusen J, Dietmaier W, Hau P, Proescholdt M, Brawanski A, Bogdahn U and Beier CP: CD133 expression and cancer stem cells predict prognosis in high-grade oligodendroglial tumors. Brain Pathol 18: 370-377, 2008.
86. Zheng X, Shen G, Yang X and Liu W: Most C6 cells are cancer stem cells: evidence from clonal and population analyses. Cancer Res 67: 3691-3697, 2008.
87. Piccirillo SG, Combi R, Cajola L, Patrizi A, Redaelli S, Bentivegna A, Baronchelli S, Maira G, Pollo B, Mangiola A, DiMeco F, Dalprà L and Vescovi AL: Distinct pools of cancer stem-like cells coexist within human glioblastomas and display different tumorigenicity and independent genomic evolution. Oncogene 28: 1807-1811, 2009.
88. Ghods AJ, Irvin D, Liu G, Yuan X, Abdulkadir IR, Tunici P, Konda B, Wachsmann-Hogiu S, Black KL and Yu JS: Spheres isolated from 9L gliosarcoma rat cell line possess chemoresistant and aggressive cancer stem-like cells. Stem Cells 25: 1645-1653, 2007.
89. Taylor MD, Poppleton H, Fuller C, Su X, Liu Y, Jensen P, Magdaleno S, Dalton J, Calabrese C, Board J, Macdonald T, Rutka J, Guha A, Gajjar A, Curran T and Gilbertson RJ: Radial glia cells are candidate stem cells of ependymoma. Cancer Cell 8: 323-335, 2005.
90. Merkle FT, Tramontin AD, Garcia-Verduno JM and Alvarez-Buylla A: Radial glia give rise to adult neural stem cells in the subventricular zone. PNAS USA 101: 17528-17532, 2004.
91. Poppleton H and Gilbertson R: Stem cells of ependymomas. Br J Cancer 96: 6-10, 2007.
92. Berger F, Gay E, Pelletier L, Tropel P and Wion D: Development of gliomas: potential role of asymmetrical cell division on neural stem cells. Lancet Oncol 5: 511-514, 2004.
93. Hanahan D and Weinberg RA: The hallmarks of cancer. Cell 100: 57-70, 2000.
94. Frank SA and Nowak MA: Cell biology: Developmental predisposition to cancer. Nature 422: 494, 2003.
95. Vescovi AL, Galli R and Reynolds BA: Brain tumour stem cells. Nature Rev Cancer 6: 425-430, 2006.
96. Uchida K, Mukai M, Okano H and Kawase T: Possible oncogenicity of subventricular zone neural stem cells: case report. Neurosurgery 55: 977-987, 2004.
97. Dahlstrand J, Collins P and Lendhal U: Expression of the class VI intermediate filament nestin in human central nervous system tumors. Cancer Res 52: 5334-5341, 1992.
98. Tohyama T, Lee VM, Rorke LB, Marvin M, McKay RD and Trojanowski JQ: Nestin expression in embryonic human neuroepitheliumn and in human neuroepithelial tumor cells. Lab Invest 66: 303-313, 1992.
99. Park KI, Ourednik L, Ourednik V, Taylor RM, Aboody KS, Auguste KI, Lachyankar MB, Redmond DE and Snyder EY: Global gene and cell replacement strategies via stem cells. Gene Ther 9: 613-624, 2002.
100. Lee J, Kotlarova S, Kotlarov Y, Li A, Su Q, Donin NM, Pastorino S, Purow BW, Christopher N, Zhang W, Park JK and Fine HA: Tumor stem cells derived from glioblastoma cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell 9: 391-403, 2006.
101. Zhang Q B, Ji XY, Huang Q, Dong J, Zhu YD and Lan Q: Differentiation profile of brain tumor stem cells: a comparative study with neural stem cells. Cell Res 16: 909-915, 2006.
102. Phillips HS, Kharbanda S, Chen R, Forrest WF, Soriano RH, Wu TD, Misra A, Nigro JM, Colman H, Soroceanu L, Williams PM, Modrusan Z, Feuerstein BG and Aldape K: Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell 9: 157-173, 2006.
103. Pfenninger CV, Roschupkina T, Hertwig F, Kottwitz D, Englund E, Bengzon J, Jacobsen SE and Nuber UA: CD133 is not present on neurogenic astrocytes in the adult subventricular zone, but on embryonic neural stem cells, ependymal cells, and glioblastoma cells. Cancer Res 67: 5727-5736, 2007.
104. Quinones-Hinojosa A and Chaichana K: The human subventricular zone: a source of new cells and a potential source of brain tumors. Exp Neurol 205: 313-324, 2007.
105. Chen D, Zhao M and Mundy GR: Bone morphogenetic protein. Growth Factors 22: 233-241, 2004.
106. Panchision DM and McKay RD: The control of neural stem cells by morphogenic signals. Curr Opin Genet Dev 12: 478-487, 2002.
107. Piccirillo SG, Reynolds BA, Zanetti N, Lamorte G, Binda E, Broggi G, Brem H, Olivi A, Dimeco F and Vescovi AL: Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells. Nature 444: 761-765, 2006.
108. Ten Dijke P: Bone morphogenetic protein signal transduction in bone. Curr Med Res Opin 22(Suppl 1): S7-11, 2006.
109. Stupp RS and Hegi ME: Targeting brain-tumor stem cells. Nature 25: 193-194, 2007.
110. Gilbertson RJ and Rich JN: Making a tumour's bed: glioblastoma stem cells and the vascular niche. Nat Rev Cancer 7: 733-736, 2007.
111. Ma Y-H, Mentlein R, Knerlich F, Kruse ML, Mehdorn H and Held-Feindt J: Expression of stem cell markers in human astrocytomas of different WHO grades. J Neurooncol 86: 31-45, 2007.
112. Kanemura Y, Mori K, Sakakibara S, Fujikawa H, Hayashi H, Nakano A, Matsumoto T, Tamura K, Imai T, Ohnishi T, Fushiki S, Nakamura Y, Yamasaki M, Okano H and Arita N: Musashi1, an evolutionary conserved neural RNA-binding protein, is a versatile marker of human glioma cells in determining their cellular origin, malignancy, and proliferative activity. Differentiation 68: 141-153, 2001.
113. Sakariassen PØ, Immervoll H and Chekenya M: Cancer stem cells as mediators of treatment resistance in brain tumors: status and controversies. Neoplasia 9: 882-892, 2009.
114. Calabrese C, Poppleton H, Kocak M, Hogg TL, Fuller C, Hamner B, Oh EY, Gaber MW, Finklestein D, Allen M, Frank A, Bayazitov IT, Zakharenko SS, Gajjar A, Davidoff and Gilbertson RJ: A perivascular niche for brain tumor stem cells. Cancer Cell 11: 69-82, 2007.
115. Huang Q, Zhang QB, Dong J, Wu YY, Shen YT, Zhao YD, Zhu YD, Diao Y, Wang AD and Lan Q: Glioma stem cells are more aggressive in recurrent tumors with malignant progression than in the primary tumor, and both can be maintained long-term in vitro. BMC Cancer 8: 304, 2008.
116. Hockfield S and McKay RDG: Identification of major cell classes in the development of mammalian nervous system. J Neurosci 5: 3310-3328, 1985.
117. Lendahl U, Zimmerman LB and McKay RDG: CNS stem cells express a new class of intermediate filament protein. Cell 60: 585-595, 1990.
118. Lin, G, Finger E and Gutierrez-Ramos JC: Expression of CD34 in endothelial cells, hematopoietic progenitors and nervous cells in foetal and adult mouse tissues. Eur J Immunol 25: 1508-1516, 1995.
119. Krum JM and Rosenstein JM: Transient coexpression of nestin, GFAP, and vascular endothelial growth factor in mature reactive astroglia following neural or brain wounds. Exp Neurol 160: 348-360, 1999.
120. Shih AH and Holland EC: Notch signaling enhances nestin expression in gliomas. Neoplasia 8: 1072-1082, 2006.
121. Abdel-Rahman A, Rao MS and Shetty AK: Nestin expression in hippocampal astrocytes after injury depends on the age of the hippocampus. Glia 47: 299-313, 2004.
122. Clarke SR, Shetty AK, Bradley JL and Turner DA: Reactive astrocytes express embryonic intermediate neurofilament nestin. Neuro Rep 5: 1885-1888, 1994.
123. Nakamura T, Xi, G, Hua Y, Hoff JT and Keep RF: Nestin expression after experimental intracerebral hemorrhage. Brain Res 981: 108-117, 2003.
124. Grigelioniené G, Blennow M, Törrök K, Fried G, Dahlin I, Lendahl U and Lagercrantz H: Cerebrospinal fluid of newborn infants contains a deglycosylated form of the intermediate filament nestin. Pediatr Res 40: 809-881, 1996.
125. Schiffer D, Manazza A and Tamagno I: Nestin expression in neuroepithelial tumors. Neurosci Lett 400: 80-85, 2006.
126. Almqvist M, Mah R, Lendahl U, Jacobsson B and Herndson G: Immunohistochemical detection of nestin in pediatric brain tumors. J Histocytochem 50: 147-158, 2002.
127. Sugawara K-I, Kurihara H, Negishi M, Saito N, Nakazato Y, Sasaki T and Takeuchi T: Nestin as a marker in proliferative endothelium in gliomas. Lab Invest 82: 345-351, 2002.
128. Strojnik T, Raskland GV, Sakariassen PO, Kavalr R and Lah T: Neural stem cell markers, nestin and musashi proteins, in the progression of human glioma: correlation of nestin with prognosis of patient survival. Surg Neur 68: 133-143, 2007.
129. Rutka JT, Ivanchuk S, Mondai S, Taylor M, Sakai K, Dirks P, Jun P, Jung S, Becker LE and Ackerley C: Co-expression of nestin and vimentin intermediate filaments in invasive human astrocytoma cells. Int J Dev Neuroscience 17: 503-515, 1999.
130. Zhang M, Song T, Yang L, Chen R, Wu L, Yang Z and Fang J: Nestin and CD133: valuable stem cell-specific markers for determining clinical outcome of glioma patients. J Exp Clin Cancer Res 27: 85, 2008.
131. Chinnaiya P, Wang M, Rojani AM, Tofilon PJ, Chakravarti A, Ang KK, Zhang H-Z, Hammond E, Curan W Jr. and Mehta MP: The prognostic value of nestin expresion in newly diagnosed glioblastoma: report from Radiation Therapy Oncology Group. Radiat Oncol 3: 32-40, 2008.
132. Vick NA, Lin MJ and Bigner DD: The role of the subependymal plate in glial tumorigenesis. Acta Neuropathol 40: 63-71, 1977.
133. Gritti A, Parati EA, Cova L, Frolichsthal P, Galli R, Wanke E, Faravelli L, Morassutti DJ, Roisen F, Nickel DD and Vescovi AL: Multipotential stem cells from the adult mouse brain proliferate and self-renew in response to basic fibroblast growth factor. J Neurosci 16: 1091-1100, 1996.
134. Doetsch F, Garcia-Verdugo JM and Alvarez-Buylla A: Regeneration of a germinal layer in the adult mammalian brain. PNAS USA 96: 11619-11624, 1999.
135. Caussinus E and Gonzalez C: Induction of tumor growth by altered stem-cell asymmetric division in Drosophila melanogaster. Nat Genet 37: 1125-1129, 2005.
136. Piccirillo SG and Vescovi AL: Brain tumour stem cells: possibilities of new therapeutic strategies. Expert Opin Biol Ther 7: 1129-1135, 2007.
137. Ganguly R and Puri IK: Mathematical model for the cancer stem hypothesis. Cell Prolif 39: 3-14, 2006.
138. Visvader JE and Lindeman GJ: Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nature Rev Cancer 8: 755-768, 2008.
139. Magavi S, Leavitt BR and Macklis JD: Induction of neurogenesis in the neocortex of adult mice. Nature 405: 951-955, 2000.
140. Liu Z, Hu X, Cai J, Liu B, Peng X, Wegner M and Qiu M: Induction of oligodendrocyte differentiation by Olig2 and Sox10: evidence for reciprocal interactions and dosage-dependent mechanisms. Dev Biol 302: 683-693, 2007.
141. Sanai N, Alvarez-Buylla A and Berger MS: Neural stem cells and the origin of gliomas. N Engl J Med 353: 811-822, 2005.
142. Gaiano N, Nye JS and Fishell G: Radial glial identity is promoted by Notch1 signaling in the murine forebrain. Neuron 26: 395-404, 2000.
143. Furnari FB, Fenton T, Bachoo RM, Mukasa A, Stommel JM, Stegh A, Hahn WC, Ligon KL, Louis DN, Brennan C, Chin L, DePinho RA and Cavenee WK: Malignant astrocytic glioma: genetics, biology, and paths to treatment. Genes Dev 21: 2683-2710, 2007.
144. Siebzehnrubl FA, Jeske I, Müller D, Buslei R, Coras R, Hahnen E, Huttner HB, Corbeil D, Kaesbauer J, Appl T, von Hörsten S and Blümcke I: Spontaneous in vitro transformation of adult neural precursors into stem-like cancer cells. Brain Pathol 19: 399-408, 2009.
145. Foroni C, Galli R, Cipelletti B, Caumo A, Alberti S, Fiocco R and Vescovi A: Resilience to transformation and inherent genetic and functional stability of adult neural stem cells ex vivo. Cancer Res 67: 725-733, 2007.
146. Walton NM, Snyder GE, Park D, Kobeissy F, Scheffler B and Steindler DA: Gliotypic neural stem cells transiently adopt tumorigenic properties during normal differentiation. Stem Cells 27: 280-289, 2009.
147. + cancer stem cells in glioblastoma. Mol Cancer 5: 67, 2006.
148. Murat A, Migliavacca E, Gorlia T, Lambiv WL, Shay T, Hamou MF, de Tribolet N, Regli L, Wick W, Kouwenhoven MC, Hainfellner JA, Heppner FL, Dietrich PY, Zimmer Y, Cairncross JG, Janzer RC, Domany E, Delorenzi M, Stupp R and Hegi ME: Stem-cell related 'self renewal' signature and high epidermal growth factor receptor expression associated with resistance to concomitant chemotherapy in glioblastoma. J Clin Oncol 26: 3015-3024, 2008.
149. Shervington A and Lu C: Expression of multidrug resistance genes in normal and cancer stem cells. Cancer Invest 26: 535-542, 2008.
150. Hambardzumyan D, Becher OJ and Holland EC: Cancer stem cells and survival pathways. Cell Cycle 7: 1371-1378, 2008.
151. Kelly PN, Dakic A, Adams JM, Nutt SL and Strasser A: Tumor growth need be driven by rare cancer stem cells. Science 317: 337, 2007.
152. Solter D and Knowles BB: Monoclonal antibody defining a stage-specific mouse embryonic antigen (SSEA-1). PNAS USA 75: 5565-5569, 1978.
153. Günther HS, Schmidt NO, Phillips HS, Kemming D, Kharbanda S, Soriano R, Modrusan Z, Meissner H, Wesphal M and Lamszus K: Glioblastoma-derived stem cell-enriched cultures from distinct subgroups according to molecular and phenotypic criteria. Oncogene 27: 2897-2909, 2008.
154. Murphy MJ, Wilson A and Trumpp A: More than just proliferation: Myc function in stem cells. Trends Cell Biol 15: 128-137, 2005.
155. Wang J, Wang H, Li Z, Wu Q, Lathia JD, McLendon RE, Hjelmeland AB and Rich JN: c-Myc is required for maintenance of glioma cancer stem cells. Plos One 3: e3769, 2008.
156. Soeda A, Inagaki A, Oka N, Ikegame Y, Aoki H, Yoshimura S, Nakashima S, Kunisada T and Iwaama T: Epidermal growth factor plays a crucial role in mitogenic regulation of human brain tumor stem cells. J Biol Chem 283: 10958-10966, 2008.
157. Hitoshi S, Alexson T, Tropepe V, Donoviel D, Elia AJ, Nye JS, Conlon RA, Mak TW, Bernstein A and van der Kooy D: Notch pathway molecules are essential for the maintenance, but not the generation, of mammalian neural stem cells. Genes Dev 16: 846-858, 2002.
158. Breier G, Albrecht U, Sterrer S and Risau W: Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation. Development 14: 521-532, 1992.
159. Zerlin M and Goldman JE: Interactions between glial progenitors and blood vessels during early postnatal corticogenesis: blood vessel contact represents an early stage of astrocyte differentiation. J Comp Neurol 387: 537-546, 1997.
160. Diabira S and Morandi X: Gliomagenesis and neural stem cells: Key role of hypoxia and concept of tumor 'neo-niche'. Med Hypotheses 70: 96-104, 2008.
161. Alvarez-Buylla A and Lim DA: For the long run: maintaining germinal niche in the adult brain. Neuron 5: 683-686, 2004.
162. Dahmane N, Sanchez P, Gitton Y, Palma V, Sun T, Beyna M, Weiner H and Ruiz i-Altaba A: The Sonic Hedgehog-Gli pathway regulates dorsal brain growth and tumorigenesis. Development 24: 5201-5212, 2001.
163. Ruiz i-Altaba A, Stecca B and Sanchez P: Hedgehog-Gli signaling in brain tumors: stem cells and paradevelopmental programs in cancer. Cancer Lett 204: 145-157, 2004.
164. Vajkoczy P, Blum S, Lamparter M, Malhammer R, Erber R, Engelhardt B, Vestweber D and Hatzopoulos AK: Multiple nature of microvascular recruitment of ex vivo-expanded embryonic endothelial cells during tumor angiogenesis. J Exp Med 197: 1755-1765, 2003.
165. Li Q, Ford MC, Lavik EB and Madri JA: Modeling the neurovascular niche: VEGF-and BDNF-mediated cross-talk between neural stem cells and endothelial cells: an in vitro study. J Neurosci Res 84: 656-668, 2006.
166. Nolan DJ, Ciarrocchi A, Mellick AS, Jaggi JS, Bambino K, Gupta S, Heikamp E, McDevitt MR, Scheinberg DA, Benezra R and Mittal V: Bone marrow-derived endothelial progenitor cells are a major determinant of nascent tumor neo vascularization. Genes Dev 21: 1546-1558, 2007.
167. Morikawa S, Baluk P, Kaidoh T, Haskell A, Jain RK and McDonald DM: Abnormalities of pericytes on blood vessels and endothelial sprouts in tumors. Am J Pathol 160: 985-1000, 2002.
168. Bababeygy SR, Cheshier SH, Hou LC, Higgins DM, Weissman IL and Tse VC: Hematopoietic stem cell-derived pericytic cells in brain tumor angio-architecture. Stem Cells Dev 17: 11-18, 2008.
169. Birnbaum T, Roider J, Schankin CJ, Padovan CS, Schichor C, Goldbrunner R and Straube A: Malignant gliomas actively recruit bone marrow stromal cells by secreting angiogenic cytokines. J Neurooncol 83: 241-247, 2007.
170. + cells in the endothelium of tumor vessels in the mouse brain. Neurosurgery 59: 374-382, 2006.
171. Glass R, Synowitz M, Kronenberg G, Walzlein JH, Markovic DS, Wang LP, Gast D, Kiwit J, Kempermann G and Kettenmann H: Glioblastoma-induced attraction of endogeneous neural precursor cells is associated with improved survival. J Neurosci 25: 2637-2646, 2005.
172. Fomchenko EI and Holland EC: Platelet-derived growth factor-mediated gliomagenesis and brain tumor recruitment. Neurosurg Clin N Am 18: 39-58, 2007.
173. Tso CL, Shintaku P, Chen J, Liu Q, Liu J, Chen Z, Yoshimoto K, Mischel PS, Cloughesy TF, Liau LM and Nelson SF: Primary glioblastomas express mesenchymal stem-like properties. Mol Cancer Res 4: 607-619, 2006.
174. Shah K, Bureau E, Kim DE, Yang K, Tang Y, Weissleder R and Breakefield XO: Glioma therapy and real-time imaging of neural precursor cell migration and tumor regression. Ann Neurol 57: 34-41, 2005.
175. Aboody KS, Brown A, Rainov NG, Bower KA, Liu S, Yang W, Small JE, Herrlinger U, Ourednik V, Black PM, Breakefield Xoa and Snyder EY: Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas. PNAS USA 97: 12846-12851, 2000.
176. Ehtesham M, Kabos P, Kabosoya A, Neuman T, Black KL and Yu JS: The use of interleukin 12-secreting neural stem cells for the treatment of intracranial glioma. Cancer Res 62: 5657-5663, 2002.
177. Shah AC, Benos D, Gillespie GY and Markert JM: Oncolytic viruses: clinical applications as vectors for the treatment of malignant gliomas. J Neurooncol 65: 203-226, 2003.
178. Kim SK, Cargioli TG, Machluf M, Yang W, Sun Y, Al-Hashem R, Kim SU, Black PM and Carroll RS: PEX-producing human neural stem cells inhibit tumor growth in a mouse glioma model. Clin Canc Res 11: 5965-5970, 2005.
179. Uhl M, Weiler M, Wick W, Jacobs AH, Weller M and Herrlinger U: Migratory neural stem cells for improved thymidine kinase-based gene therapy for malignant gliomas. Biochem Biophys Res Commun 328: 125-129, 2005.
180. Rath P, Shi H, Maruniak JA, Litofsky NS, Maria BL and Kirk MD: Stem cells as vectors to deliver HSV/tk gene therapy for malignant gliomas. Curr Stem Cell Res Ther 4: 44-49, 2009.
181. Tyler MA, Ulasov IV, Sonabend AM, Nandi S, Han Y, Marler S, Roth J and Lesniak MS: Neural stem cells target intracranial glioma to deliver an oncolytic adenovirus in vivo. Gene Ther 16: 262-278, 2009.
182. Jeon JY, An JH, Kim SU, Park HG and Lee MA: Migration of human neural stem cells toward an intracranial glioma. Exp Mol Med 40: 84-91, 2008.
183. Nakamura K, Ito Y, Kawano Y, Kurozumi K, Kobune M, Tsuda H, Bizen A, Honmou O, Niitsu Y and Hamada H: Antitumor effect of genetically engineered mesenchymal stem cells in a rat model. Gene Ther 11: 1155-1164, 2004.
184. Nakamizo A, Marini F, Amano T and Khan A: Human bone-marrow derived mesenchymal stem cells in the treatment of gliomas. Cancer Res 65: 3307-3318, 2005.
185. Tabatabai G, Bähr O, Möhle R, Eyüpoglu IY, Boehmler AM, Wischhusen J, Rieger J, Blümcke I, Weller M and Wick W: Lessons from the bone marrow how malignant glioma cells attract adult hematopoietic progenitor cells. Brain 128: 2200-2211, 2005.
186. Okano H, Imai T and Okabe M: Musashi: a translational regulator of cell fate. J Cell Sci 115: 1355-1359, 2002.
187. Xu F and Zhu J-H: Stem cells tropism for malignant gliomas. Neurosci Bull 23: 363-369, 2007.
188. Honeth G, Staflin K, Kalliomäki S, Lindvall M and Kjellman C: Chemokine-directed migration of tumor-inhibitory neural progenitor cells towards an intracranially growing glioma. Exp Cell Res 312: 1265-1276, 2006.
189. Chen HI, Bakshi A, Royo NC, Magge SN and Watson DJ: Neural stem cells as biological minipumps: a faster route to cell therapy for the CNS. Curr Stem Cell Res Ther 2: 13-22, 2007.
190. Staflin K, Lindvall M, Zuchner T and Lundberg C: Instructive cross-talk between neural progenitor cells and gliomas. J Neurosci Res 85: 2147-2159, 2007.
191. Zhao D, Najbauer J, Garcia E, Metz MZ, Gutova M, Glackin CA, Kim SU and Aboody KS: Neural stem cell tropism to glioma: critical role of tumor hypoxia. Mol Cancer Res 6: 1819-1829, 2008.
192. Ayuso-Sacido A, Graham C, Greenfield JP and Boockvar JA: The duality of epidermal growth factor receptor (EGFR) signalling and neural stem cell phenotype: cell enhancer or cell transformer? Curr Stem Cell Res Ther 1: 387-394, 2006.
193. Walzlein JH, Synowitz M, Engels B, Markovic DS, Gabrusiewicz K, Nikolaev E, Yoshikawa K, Kaminska B, Kempermann G, Uckert W, Kaczmarek L, Kettenmann H and Glass R: The antitumorigenic response of neural precursors depends on subventricular proliferation and age. Stem Cells 26: 2945-2954, 2008.
194. Barresi V, Belluardo N, Sipione S, Mudò G, Cattaneo E and Condorelli DF: Transplantation of prodrug-converting neural progenitor cells for brain tumor therapy. Cancer Gene Ther 10: 396-402, 2003.
195. Oh MC and Lim DA: Novel treatment strategies for malignant gliomas using neural stem cells. Neurotherapeutics 6: 458-463, 2009.
196. Amariglio N, Hirshberg A, Scheithauer BW, Cohen Y, Loewenthal R, Trankhtenbrot L, Paz N, Koren-Michowitz M, Waldman D, Leider-Trejo L, Toren A, Constantini S and Rehcavi G: Donor-derived brain tumor following neural stem cell transplantation in an ataxia-teleangectasia patient. Plos Med 6: e1000029, 2009.
197. Colin C, Baeza N, Tong S, Bouvier C, Quilichini B, Durbec P and Figarella-Branger D: In vitro identification and functional characterization of glial precursor cells in human gliomas. Neuropathol Appl Neurobiol 32: 189-202, 2006.
198. Mezey Chandross KJ, Harta G, Maki RA and McKercher SR: Turning blood into brain; cells bearing neuronal antigens generated in vivo from bone marrow. Science 290: 1779-1782, 2000.
199. + tissue-committed stem cells. Biol Cell 2: 133-146, 2005. (Pubitemid 40298268)
200. Zipori D: The nature of stem cells: state rather than entity. Nat Rev Genet 5: 873-878, 2004.
201. Kislin KL, McDonough WS, Eschbacher JM, Armstrong BA and Berens E: NHERF-1: modulator of glioblastoma cell migration and invasion. Neoplasia 11: 377-387, 2009.
202. Sontheimer H: A role for glutamate in growth and invasion of primary brain tumors. J Neurochem 105: 287-295, 2008.